Viking Therapeutics Inc (VKTX)
42.25
+0.76
(+1.83%)
USD |
NASDAQ |
Dec 20, 16:00
42.85
+0.60
(+1.42%)
After-Hours: 20:00
Viking Therapeutics Shareholders Equity (Quarterly): 911.45M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Eli Lilly and Co | 14.24B |
| Pfizer Inc | 92.29B |
| Merck & Co Inc | 44.50B |
| Vertex Pharmaceuticals Inc | 15.63B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.89M |
| Total Liabilities (Quarterly) | 26.44M |